Abstract: A method of detecting the presence of a prostate cancer field defect in a human subject. The method includes (a) obtaining genomic DNA from the human subject and (b) determining methylation status in at least one target region selected from the group consisting of PLA2G16, CAV1, EVX1, MCF2L, FGF1, NCR2, WNT2, EXT1, and SPAG4, wherein methylation changes indicate the presence of prostate cancer or a prostate cancer field defect, wherein the change is relative to tissue from a second human subject who does not have prostate cancer.

Abstract: In accordance with some embodiments, systems, methods and media for stochastic exposure coding for continuous time-of-flight imaging are provided. In some embodiments, a method for estimating the depth of a scene is provided, comprising: stochastically selecting active slots based on a probability p; causing, during active slots, a light source to emit light modulated by a first modulation function toward a scene; causing, during active slots, an image sensor to generate a first, second, and third value based on received light from a portion of the scene and a first, second, and third demodulation function, respectively; inhibiting the light source during inactive slots; determining, for each of the active slots, depth estimates for the portion of the scene based on the first, second, and third value; and determining a depth estimate for the portion of the scene based on the depth estimates for the active slots.

Abstract: This invention relates to peptides having antiviral properties. The antiviral peptides comprise membrane transiting peptides, and active fragments and derivatives of such peptides. The antiviral peptides exhibit activity against a broad spectrum of viruses, including enveloped and nonenveloped viruses, and are used in pharmaceutical compositions to prevent and/or treat viral infections.